Neurocrine Biosciences, Inc. (NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs Transcript
Summarize this article with:
SA Transcripts157.38K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Neurocrine Biosciences, Inc. (NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs December 16, 2025 12:00 PM EST Company Participants Todd TushlaKyle Gano - CEO & DirectorSanjay Keswani - Chief Medical OfficerJaz SinghMatthew Abernethy - Chief Financial OfficerJude Onyia - Chief Scientific Officer Conference Call Participants John KrystalBrian Abrahams - RBC Capital Markets, Research DivisionSean Laaman - Morgan Stanley, Research DivisionTazeen Ahmad - BofA Securities, Research DivisionEvan Seigerman - BMO Capital Markets Equity ResearchJay Olson - Oppenheimer & Co. Inc., Research DivisionMyles Minter - William Blair & Company L.L.C., Research DivisionCorinne Jenkins - Goldman Sachs Group, Inc., Research DivisionYigal Nochomovitz - Citigroup Inc., Research DivisionMohit Bansal - Wells Fargo Securities, LLC, Research DivisionAshwani Verma - UBS Investment Bank, Research DivisionAnupam Rama - JPMorgan Chase & Co, Research DivisionSumant Kulkarni - Canaccord Genuity Corp., Research Division Presentation Todd Tushla Good morning, and good afternoon. My name is Todd Tushla, I'm the Vice President of Investor Relations at Neurocrine Biosciences. And on behalf of our entire company, welcome to our 2025 R&D Day, whether you're here in person, on the webcast or reading the transcript, we're grateful for your time. We will be making forward-looking statements today. So I refer you to our latest SEC disclosures. Our speakers for today from Neurocrine will be Kyle Gano, Chief Executive Officer; Sanjay Keswani, our Chief Medical Officer; and Jude Onyia, our Chief Scientific Officer. As far as tenure at Neurocrine, Sanjay joined us in June. Jude joined us in 2021, and Kyle joined us in 2001. Wow, that was a long time ago. We're also fortunate to have with us today Dr. John Krystal, a world-leading expert in the field of neurology and psychiatry and a Professor at Yale University. Dr. Krystal, thank you for being here. Dr. Krystal will be joined on stage by Jaz Singh, our Vice President Of Neuropsychiatry Development for